Clinical trial · Interventional
Quality of Life After Oesophageal or Gastric Cancer Surgery
Quality of Life and Supportive Care Needs After Oesophageal or Gastric Cancer Surgery.
NCT01657175CI-TRIAL-00026933completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aim to assess quality of life of patients 0-5 years after oesophageal or gastric cancer surgery and to develop and test an information and support program aiming to enhance the patients quality of life (QOL) after surgery. The project contains 3 part-studies focusing on the patients life after surgery. Data will be collected through focus group interviews and a randomized controlled trial (RCT) study.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Oesophageal Cancer | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Supportive care | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Supportive care
- description
- The patients randomized to the supportive care arm get an extended supportive care during the first year after surgery.
- interventionNames
- Other: Supportive care
- type
- NO_INTERVENTION
- label
- Control
- description
- The patients randomized to the control group get "care as usual"
Primary outcomes (1)
- measure
- Quality of Life
- timeFrame
- Change of QOL from discharge (discharge= approximately 2-4 weeks after surgery) to 6 months after discharge
- description
- Quality of life will be measured at discharge, 2 weeks, 2, 4 and 6 months after discharge (discharge= approximately 2-4 weeks after surgery). Quality of life is evaluated using EORTC quality of life instruments at discharge and 2 weeks, 2,4 and 6 months after discharge.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with any stage tumours in the distal third of the oesophagus including type II tumours at the gastro-oesophageal junction * Transthoracic oesophageal resection with gastric tube reconstructions and circular stapled anastomoses in the upper right chest Postoperative clinical courses without complications, and postoperative anastomotic radiograms without anastomotic leakage * Macro and microscopically tumour free upper resection margins Willingness, physical and mental capability to comply with the result of the randomization, and ability to follow the study protocol * Adult \>18 years * Living in the southern of Sweden (Skåne county) Exclusion Criteria: * Preoperative or planned postoperative chemotherapy or radiotherapy to the tumour area known at the time of discharge from the hospital. * Postoperative need for continuous treatment with proton pump inhibitors (PPIs) or histamine-2 blockers. Treatment with steroidal or non steroidal anti inflammatory drugs other than occasionally * Known allergy or side effects to PPIs preventing continuous treatment for one year * Present drug or alcohol abuse * Failure to attend at least one postoperative visit
References
Publications (0)
Data not yet available
No reference posted for this study.